Procurement 4.0 Preparing for Digital Transformation

You may also like

• 
  McKinsey

  In 2007, medical leaders from across the pharmaceutical industry assembled to develop a common understanding of a ten-year vision for Medical Affairs. With five years now past, it is hardly surprising that significant change has occurred in the world in which the pharmaceutical industry operates, especially given the remarkable economic environment and the continued acceleration of technological change.

  

  Pharma Medical Affairs 2020 and beyond

  $0.00 McKinsey
  
• 
  Deloitte

  SUPPLY chains traditionally are linear in nature, with a discrete progression of design, plan, source, make, and deliver. Today, however, many supply chains are transforming from a staid sequence to a dynamic, interconnected system that can more readily incorporate ecosystem partners and evolve to a more optimal state over time.

  

  The rise of the digital supply network

  $0.00 Deloitte
  
• 
  LEK

  Artificial intelligence (AI) has the potential to transform the pharmaceutical industry. Each of the major pharma players is investing in the technology at some level, and there are a growing number of applications that address target and drug discovery, preclinical and clinical development, and postapproval activities.

  

  Artificial Intelligence in Life Sciences

  $0.00 LEK